[96a5a0]: / output / allTrials / identified / NCT00178373_identified.json

Download this file

476 lines (476 with data), 20.5 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
{
"info": {
"nct_id": "NCT00178373",
"official_title": "Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer",
"inclusion_criteria": "* Patient is longer than one-month post chemotherapy and/or radiation treatment for an initial diagnosis of cancer\n* Patient is 18 years of age or older\n* Patient is able to swallow medication\n* Patient has a Brief Fatigue Inventory (BFI) question #3 \"fatigue worst\" score of 2 or greater\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patient has ever taken modafinil (PROVIGIL)\n* Patient has taken an anticonvulsant for a seizure disorder; has taken any of the following on a regular basis within the past 30 days, a psychostimulant (e.g., amphetamines, methylphenidate [Ritalin], pemoline [Cylert]), or a monoamine oxidase inhibitor (MAOIs)\n* Patient has a history of clinically significant cardiac disease, uncontrolled hypertension, alcohol or drug abuse, severe headaches, glaucoma, seizure disorder, narcolepsy, a psychotic disorder, or Tourette's syndrome\n* Patient presently taking on a regular basis:\n\n * an anticoagulant (Coumadin [warfarin], heparin); note that low dose Coumadin (1 mg by mouth daily) given for maintenance of venous access devices is acceptable\n * alpha-interferon or interleukin-2,\n * a corticosteroid (dexamethasone, prednisone, prednisolone)\n* Patient has a narrowing (pathological or iatrogenic) or obstruction of the gastrointestinal tract\n* Patient is currently pregnant or nursing (if currently using a steroidal contraceptive for fertility control, participant must agree to use a barrier method of contraception during the study and for one full menstrual cycle following the study\n* Patient has uncontrolled anemia; receiving treatment for anemia and currently stable is acceptable",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patient is longer than one-month post chemotherapy and/or radiation treatment for an initial diagnosis of cancer",
"criterions": [
{
"exact_snippets": "longer than one-month post chemotherapy",
"criterion": "post chemotherapy duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
},
{
"exact_snippets": "longer than one-month post ... radiation treatment",
"criterion": "post radiation treatment duration",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "month"
}
}
]
},
{
"exact_snippets": "initial diagnosis of cancer",
"criterion": "initial diagnosis of cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient is 18 years of age or older",
"criterions": [
{
"exact_snippets": "18 years of age or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Patient is able to swallow medication",
"criterions": [
{
"exact_snippets": "able to swallow medication",
"criterion": "ability to swallow medication",
"requirements": [
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has a Brief Fatigue Inventory (BFI) question #3 \"fatigue worst\" score of 2 or greater",
"criterions": [
{
"exact_snippets": "Brief Fatigue Inventory (BFI) question #3 \"fatigue worst\" score of 2 or greater",
"criterion": "fatigue worst score",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "healthy volunteers",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patient has ever taken modafinil (PROVIGIL)",
"criterions": [
{
"exact_snippets": "Patient has ever taken modafinil (PROVIGIL)",
"criterion": "modafinil (PROVIGIL) usage",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has taken an anticonvulsant for a seizure disorder; has taken any of the following on a regular basis within the past 30 days, a psychostimulant (e.g., amphetamines, methylphenidate [Ritalin], pemoline [Cylert]), or a monoamine oxidase inhibitor (MAOIs)",
"criterions": [
{
"exact_snippets": "Patient has taken an anticonvulsant for a seizure disorder",
"criterion": "anticonvulsant use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "has taken any of the following on a regular basis within the past 30 days, a psychostimulant (e.g., amphetamines, methylphenidate [Ritalin], pemoline [Cylert])",
"criterion": "psychostimulant use",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within the past 30 days"
}
]
},
{
"exact_snippets": "has taken any of the following on a regular basis within the past 30 days, ... a monoamine oxidase inhibitor (MAOIs)",
"criterion": "monoamine oxidase inhibitor use",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within the past 30 days"
}
]
}
]
},
{
"line": "* Patient has a history of clinically significant cardiac disease, uncontrolled hypertension, alcohol or drug abuse, severe headaches, glaucoma, seizure disorder, narcolepsy, a psychotic disorder, or Tourette's syndrome",
"criterions": [
{
"exact_snippets": "history of clinically significant cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "clinical significance",
"expected_value": true
}
]
},
{
"exact_snippets": "uncontrolled hypertension",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "alcohol or drug abuse",
"criterion": "substance abuse",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "severe headaches",
"criterion": "headaches",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
}
]
},
{
"exact_snippets": "glaucoma",
"criterion": "glaucoma",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "seizure disorder",
"criterion": "seizure disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "narcolepsy",
"criterion": "narcolepsy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "psychotic disorder",
"criterion": "psychotic disorder",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Tourette's syndrome",
"criterion": "Tourette's syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient presently taking on a regular basis:",
"criterions": [
{
"exact_snippets": "Patient presently taking on a regular basis",
"criterion": "medication usage",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": "regular"
}
]
}
]
},
{
"line": "* an anticoagulant (Coumadin [warfarin], heparin); note that low dose Coumadin (1 mg by mouth daily) given for maintenance of venous access devices is acceptable",
"criterions": [
{
"exact_snippets": "an anticoagulant (Coumadin [warfarin], heparin)",
"criterion": "anticoagulant use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "low dose Coumadin (1 mg by mouth daily) given for maintenance of venous access devices is acceptable",
"criterion": "low dose Coumadin for venous access devices",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* alpha-interferon or interleukin-2,",
"criterions": [
{
"exact_snippets": "alpha-interferon",
"criterion": "alpha-interferon",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "interleukin-2",
"criterion": "interleukin-2",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* a corticosteroid (dexamethasone, prednisone, prednisolone)",
"criterions": [
{
"exact_snippets": "a corticosteroid (dexamethasone, prednisone, prednisolone)",
"criterion": "corticosteroid",
"requirements": [
{
"requirement_type": "types",
"expected_value": [
"dexamethasone",
"prednisone",
"prednisolone"
]
}
]
}
]
},
{
"line": "* Patient has a narrowing (pathological or iatrogenic) or obstruction of the gastrointestinal tract",
"criterions": [
{
"exact_snippets": "narrowing (pathological or iatrogenic) ... of the gastrointestinal tract",
"criterion": "narrowing of the gastrointestinal tract",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "obstruction of the gastrointestinal tract",
"criterion": "obstruction of the gastrointestinal tract",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has uncontrolled anemia; receiving treatment for anemia and currently stable is acceptable",
"criterions": [
{
"exact_snippets": "Patient has uncontrolled anemia",
"criterion": "anemia",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "receiving treatment for anemia and currently stable is acceptable",
"criterion": "anemia treatment",
"requirements": [
{
"requirement_type": "stability",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Patient is currently pregnant or nursing (if currently using a steroidal contraceptive for fertility control, participant must agree to use a barrier method of contraception during the study and for one full menstrual cycle following the study",
"criterions": [
{
"exact_snippets": "Patient is currently pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "currently nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "currently using a steroidal contraceptive for fertility control",
"criterion": "steroidal contraceptive use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "participant must agree to use a barrier method of contraception during the study and for one full menstrual cycle following the study",
"criterion": "barrier method of contraception",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
}
],
"failed_miscellaneous": []
}